Literature DB >> 14996911

EGFR signaling to p120-catenin through phosphorylation at Y228.

Deborah J Mariner1, Michael A Davis, Albert B Reynolds.   

Abstract

Epidermal growth factor receptor (EGFR) signals to p120(ctn) (p120), implying a role for EGFR in modulating cell-cell adhesion in epithelial tissues. p120 controls cadherin turnover, and may have other roles that modulate cadherin adhesiveness. To clarify the role for EGFR and other tyrosine kinases in regulating p120 function, we have generated and characterized a new phosphospecific antibody to p120 Y228, as well as a novel siRNA-based reconstitution system for analyzing roles of individual p120 phosphorylation events. In A431 cells, epidermal growth factor induced striking p120 phosphorylation at Y228. Y228-phosphorylated p120 localized to adherens junctions and lamellipodia, and was significantly enhanced in cells around the colony periphery. A screen of carcinoma cell lines revealed that some contain unusually high steady state levels of Y228 phosphorylation, suggesting that disregulated kinase activity in tumors may affect adhesion by constitutive cross talk to cadherin complexes. Despite these observations, mutation of Y228 and other prominent Src-associated p120 phosphorylation sites did not noticeably reduce the ability of E-cadherin to assemble junctions and induce compaction of cultured cells. Although A431 cells display significant activation of both EGFR and Src kinases, our data suggest that these account for only a fraction of the steady state activity that targets p120 Y228, and that Src family kinases are not necessary intermediates for epidermal growth factor-induced signaling to p120 Y228.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996911     DOI: 10.1242/jcs.01001

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  46 in total

Review 1.  Phosphorylation and isoform use in p120-catenin during development and tumorigenesis.

Authors:  Ji Yeon Hong; Il-Hoan Oh; Pierre D McCrea
Journal:  Biochim Biophys Acta       Date:  2015-10-23

2.  Shared molecular mechanisms regulate multiple catenin proteins: canonical Wnt signals and components modulate p120-catenin isoform-1 and additional p120 subfamily members.

Authors:  Ji Yeon Hong; Jae-Il Park; Kyucheol Cho; Dongmin Gu; Hong Ji; Steven E Artandi; Pierre D McCrea
Journal:  J Cell Sci       Date:  2010-11-23       Impact factor: 5.285

3.  Epidermal growth factor inhibits glycogen synthase kinase-3 (GSK-3) and beta-catenin transcription in cultured ARPE-19 cells.

Authors:  Walter Krugluger; Stefan Seidel; Kerstin Steindl; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-10       Impact factor: 3.117

Review 4.  p120-catenin: Past and present.

Authors:  Albert B Reynolds
Journal:  Biochim Biophys Acta       Date:  2006-09-19

5.  The regulatory or phosphorylation domain of p120 catenin controls E-cadherin dynamics at the plasma membrane.

Authors:  Yuri Fukumoto; Yasushi Shintani; Albert B Reynolds; Keith R Johnson; Margaret J Wheelock
Journal:  Exp Cell Res       Date:  2007-07-31       Impact factor: 3.905

Review 6.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

7.  PDGF receptor activation induces p120-catenin phosphorylation at serine 879 via a PKCalpha-dependent pathway.

Authors:  Meredith V Brown; Patrick E Burnett; Mitchell F Denning; Albert B Reynolds
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

8.  Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells.

Authors:  Cécile Boscher; Yu Zi Zheng; Ramya Lakshminarayan; Ludger Johannes; James W Dennis; Leonard J Foster; Ivan R Nabi
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

9.  Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.

Authors:  Poonam R Molli; Liana Adam; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

10.  Retrotransposition and mutation events yield Rap1 GTPases with differential signalling capacity.

Authors:  Tomasz Zemojtel; Marlena Duchniewicz; Zhongchun Zhang; Taisa Paluch; Hannes Luz; Tobias Penzkofer; Jürgen S Scheele; Fried J T Zwartkruis
Journal:  BMC Evol Biol       Date:  2010-02-19       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.